[{"NetIncomeLoss_1_Q3_USD":-50253.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q3_USD":4050000.0,"RepaymentsOfRelatedPartyDebt_1_Q3_USD":99627.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":107226360.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":10722636.0,"AssetsCurrent_0_Q3_USD":1339328.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":43342.0,"NetCashProvidedByUsedInInvestingActivities_1_Q3_USD":-115000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"Liabilities_0_Q3_USD":4113342.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1164723.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":10.0,"PaymentsOfStockIssuanceCosts_1_Q3_USD":327750.0,"NetCashProvidedByUsedInFinancingActivities_1_Q3_USD":116347623.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":115000384.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_1_Q3_USD":43342.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"PrepaidExpenseCurrent_0_Q3_USD":174605.0,"Assets_0_Q3_USD":116339712.0,"ProceedsFromIssuanceOfCommonStock_1_Q3_USD":25000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":0.0,"AdditionalPaidInCapital_0_Q3_USD":5050857.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1164723.0,"LiabilitiesCurrent_0_Q3_USD":88342.0,"NetCashProvidedByUsedInOperatingActivities_1_Q3_USD":-182900.0,"DeferredTaxAssetsGross_0_Q3_USD":11000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q3_USD":1164723.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-51253.0,"StockholdersEquity_0_Q3_USD":5000010.0,"ProfitLoss_1_Q3_USD":-51253.0,"CashFDICInsuredAmount_0_Q3_USD":250000.0,"DeferredTaxAssetsValuationAllowance_0_Q3_USD":11000.0,"ProceedsFromIssuanceOfWarrants_1_Q3_USD":4050000.0,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":116339712.0,"InvestmentIncomeInterest_1_Q3_USD":384.0,"OperatingIncomeLoss_1_Q3_USD":-50637.0,"NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_1_Q3_USD":99627.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"IncreaseDecreaseInPrepaidExpense_1_Q3_USD":174605.0,"Ticker":"QSI","CIK":"1816431","name":"HIGHCAPE CAPITAL ACQUISITION CORP.","OfficialName":"Quantum-Si Incorporated Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"597769692.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201113"}]